NFE2L2 and COVID-19: The benefits of nutritional Nrf2 agonists for COVID-19 (and burden of lifestyle diseases) as part of a “Food as medicine” concept [127] needs to be assessed through large studies by employing a double-blind, placebo-controlled design to stand on a robust scientific ground.